TrialCancer research and treatment2019

Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01).

In Hae Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.